TREE NEWS update: China’s State Administration for Market Regulation released three technical guidance documents for clinical trials of food for special medical purposes, covering sarcopenia, dyslipidemia, and obesity and bariatric surgery. The documents set out trial requirements for these specific full-nutrition formula foods. The regulator published the guidance as a set of three principles.
China Market Regulator Issues Clinical Trial Guidance for Three Medical Food Categories
AI take
The significance lies in the regulator moving from broad categories to named clinical indications, which raises the evidence bar for full-nutrition formulas and shifts differentiation toward trial design rather than formulation alone. It affects medical food makers, contract research organisations and trial sites positioned in these therapeutic areas. Whether the guidance becomes a de facto template for further indications is the open question.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
26m ago
Former Guangxi Investment Group General Manager Liu Minghong Expelled from Party and Public Office
36m ago
China Enacts 6 Mandatory National Standards and 248 Recommended Standards from Oct 1
44m ago
Polymarket Adds Deposit Limits, Self-Exclusion Tools for Users
53m ago
SEC Proposes First Major Update to Transfer Agent Rules Since 1970s, Eyes Blockchain
1h ago
Cuomo Warns Crypto Rule Progress Could Be Undone If Democrats Win Congress
1h ago
SEC Sues Four Firms Over $15M Crypto Scams Run Via WhatsApp